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Dendritic cells (DCs) were first described by Steinman and Cohn in
1973 (1) as cells provided of efficient antigen-presenting capacity.
Steinmann received the Nobel Prize in 2011 for having revealed the
pivotal role of DCs in linking innate and adaptive immunity and
initiating antigen-specific immunity (2). The work conducted by
Steinman was also instrumental in determining the role of DCs not
only in activating adaptive immunity but also in controlling adap-
tive anti-self reactions by inducing and maintaining self-tolerance
both at central and peripheral level (3).
Dendritic cells are highly heterogeneous. Two major classes
of DCs have been described: classical or conventional and plas-
macytoid DCs (pDCs). Classical DCs are cells of myeloid ori-
gin capable of efficiently capturing microbial antigens, and, after
homing to lymph nodes and antigen processing, present these
antigens to prime naive T cells. Diversely, pDCs are poorly
phagocytic but recognize viruses very well. Upon encounter of
microbial stimuli, they also differentiate into efficient antigen-
presenting cells and express high levels of type I interferons
(IFNs) (4). Based on tissue localization, transcription factor, and
surface markers expression, classical DCs have been subdivided
in a continuously growing number of subtypes (5, 6). Subsets
expressing CD4/CD11b or CD8α/CD103 resides in secondary
lymphoid organs; under healthy conditions lymph nodes con-
tain additional subsets of partially matured steady state migratory
DCs that transport self-antigens into lymph nodes for tolerance
induction (7–10).
The DC capacity of inducing both immunity and tolerance
may seem a contradictory aspect of DC biology, nevertheless the
acquisition of these two different properties may depend on stim-
uli DC are exposed to or may be a specific feature of different DC
subsets.
Dendritic cells sense the presence of exogenous microbial
signals through germline-encoded pattern-recognition receptors
(PRRs), which recognize molecular patterns expressed by various
microorganisms or endogenous danger signals. The consequences
of the activation of these receptors on DCs have been implicated
in the acquisition of the immunogenic functions characterized by
the increase of antigen presentation and costimulation as well as
the release of proinflammatory cytokines. The attainment of the
tolerogenic function by DCs seems instead to be more linked to
the exposure to endogenous factors sensed in peripheral tissues
under steady state conditions.
In the present Research topic, contributing articles describe a
number of aspects determining the tolerogenic or immunogenic
functions of DCs. In particular, the themes that will be discussed
concern the role of DCs in controlling the threshold of activation
of T cells; the role of the diverse costimulatory molecules, either
secreted by DC subsets or expressed on the cell surface, in deter-
mining the DC immunogenic or tolerogenic functions; the role
of endogenous or exogenous stimuli in influencing the DC func-
tional state; some specific roles of DCs in preventing particular
organ autoimmunity and, finally, possible therapeutic potentials
of immunogenic or tolerogenic DCs.
Understanding the mechanisms that regulate the functional
properties of DCs will allow exploiting these cells in new effective
therapeutic strategies, including cancer immunotherapy and con-
trol of autoimmunity, to improve intervention outcomes. Under-
standing DC biology and their responses to activating stimuli will
also help the identification of novel adjuvants to be used in new
vaccine formulations.
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